BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9449704)

  • 1. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants.
    Rohlmann A; Gotthardt M; Hammer RE; Herz J
    J Clin Invest; 1998 Feb; 101(3):689-95. PubMed ID: 9449704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor.
    Herz J; Qiu SQ; Oesterle A; DeSilva HV; Shafi S; Havel RJ
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4611-5. PubMed ID: 7753850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice.
    Martins IJ; Hone E; Chi C; Seydel U; Martins RN; Redgrave TG
    J Lipid Res; 2000 Feb; 41(2):205-13. PubMed ID: 10681404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained somatic gene inactivation by viral transfer of Cre recombinase.
    Rohlmann A; Gotthardt M; Willnow TE; Hammer RE; Herz J
    Nat Biotechnol; 1996 Nov; 14(11):1562-5. PubMed ID: 9634821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist.
    Willnow TE; Sheng Z; Ishibashi S; Herz J
    Science; 1994 Jun; 264(5164):1471-4. PubMed ID: 7515194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.
    Linton MF; Hasty AH; Babaev VR; Fazio S
    J Clin Invest; 1998 Apr; 101(8):1726-36. PubMed ID: 9541504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the low-density-lipoprotein-receptor-related protein and its relevance to chylomicron-remnant metabolism.
    Szanto A; Balasubramaniam S; Roach PD; Nestel PJ
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):791-4. PubMed ID: 1471994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased hepatic expression of the low-density lipoprotein (LDL) receptor and LDL receptor-related protein in aging rats is associated with delayed clearance of chylomicrons from the circulation.
    Field PA; Gibbons GF
    Metabolism; 2000 Apr; 49(4):492-8. PubMed ID: 10778874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extrahepatic receptor-associated protein-sensitive mechanism is involved in the metabolism of triglyceride-rich lipoproteins.
    van Vlijmen BJ; Rohlmann A; Page ST; Bensadoun A; Bos IS; van Berkel TJ; Havekes LM; Herz J
    J Biol Chem; 1999 Dec; 274(49):35219-26. PubMed ID: 10575007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.
    Hussain MM; Maxfield FR; Más-Oliva J; Tabas I; Ji ZS; Innerarity TL; Mahley RW
    J Biol Chem; 1991 Jul; 266(21):13936-40. PubMed ID: 1713211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the roles of the low density lipoprotein (LDL) receptor and the LDL receptor-related protein/alpha 2-macroglobulin receptor in chylomicron remnant removal in the mouse in vivo.
    Choi SY; Cooper AD
    J Biol Chem; 1993 Jul; 268(21):15804-11. PubMed ID: 7687998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver.
    de Faria E; Fong LG; Komaromy M; Cooper AD
    J Lipid Res; 1996 Jan; 37(1):197-209. PubMed ID: 8820115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.
    Véniant MM; Zlot CH; Walzem RL; Pierotti V; Driscoll R; Dichek D; Herz J; Young SG
    J Clin Invest; 1998 Oct; 102(8):1559-68. PubMed ID: 9788969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E.
    Yu KC; Jiang Y; Chen W; Cooper AD
    J Lipid Res; 2000 Nov; 41(11):1715-27. PubMed ID: 11060341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of hepatic chylomicron remnant clearance.
    Willnow TE
    Diabet Med; 1997 Aug; 14 Suppl 3():S75-80. PubMed ID: 9272618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of coagulation factor VIII in very low-density lipoprotein receptor knockout mice.
    Bovenschen N; van Dijk KW; Havekes LM; Mertens K; van Vlijmen BJ
    Br J Haematol; 2004 Sep; 126(5):722-5. PubMed ID: 15327526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo.
    Willnow TE; Armstrong SA; Hammer RE; Herz J
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4537-41. PubMed ID: 7538675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL receptor-related protein mediates cell-surface clustering and hepatic sequestration of chylomicron remnants in LDLR-deficient mice.
    Yu KC; Chen W; Cooper AD
    J Clin Invest; 2001 Jun; 107(11):1387-94. PubMed ID: 11390420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudo type III dyslipoproteinemia is associated with normal fibroblast lipoprotein receptor activity.
    Giroux LM; Cohn JS; LaMarre J; Davignon J
    Atherosclerosis; 1997 Jul; 132(1):85-94. PubMed ID: 9247363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein.
    Beisiegel U; Weber W; Ihrke G; Herz J; Stanley KK
    Nature; 1989 Sep; 341(6238):162-4. PubMed ID: 2779654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.